Zydus gains FDA approval for urinary tract infection medication
Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.
Zydus Life gets US FDA nod for UTI treatment drug Methenamine
Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Methenamine Hippurate Tablets.
Zydus Lifesciences shares fly 7% as USFDA okays cancer drug Dasatinib
The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...
Pharmabiz7d
NPPA notifies retail price of 53 formulations
The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...